Location History:
- Kufstein, AT (2003)
- Kundl, AT (2013)
- Ebbs, AT (2012 - 2014)
Company Filing History:
3 out of 148 
2 out of 18 
1 out of 55 Years Active: 2003-2014
Title: Innovations and Contributions of Andreas Berger
Introduction
Andreas Berger is a notable inventor based in Ebbs, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of pleuromutilins and related compounds. With a total of 6 patents to his name, his work has had a considerable impact on medicinal chemistry.
Latest Patents
Berger's latest patents include a process for the preparation of pleuromutilins, which focuses on producing high-purity products suitable for large-scale production. This process involves a specific configuration of the carbon atom at the piperidine ring, which is crucial for the efficacy of the compounds. Another significant patent relates to the stereoselective enzymatic hydrolysis of 5-methyl-3-nitromethyl-hexanoic acid ester. This invention outlines methods for preparing various forms of this compound, including enantioenriched and enantiopure forms, which are essential for pharmaceutical applications.
Career Highlights
Throughout his career, Andreas Berger has worked with prominent companies in the pharmaceutical industry, including Sandoz AG and Nabriva Therapeutics AG. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Berger has collaborated with notable colleagues such as Martin Albert and Hubert Sturm. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Andreas Berger's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic agents.